Center for Scientific Review; Notice of Closed Meetings, 29199-29200 [2014-11649]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 98 / Wednesday, May 21, 2014 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Alternative Medicine; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel, Training Grants.
Date: June 19, 2014.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Boulevard, Bethesda, MD 20814,
(Telephone Conference Call).
Contact Person: Peter Kozel, Ph.D.,
Scientific Review Officer, NCCAM, 6707
Democracy Boulevard, Suite 401, Bethesda,
MD 20892–5475, 301–496–8004, kozelp@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS).
Dated: May 15, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–11650 Filed 5–20–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
VerDate Mar<15>2010
17:42 May 20, 2014
Jkt 232001
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Bacterial
Pathogenesis.
Date: June 9, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Richard G. Kostriken,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192,
MSC 7808, Bethesda, MD 20892, 301–402–
4454, kostrikr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, RFA Panel:
Animal Models and Human Investigation
Cross-Training.
Date: June 10, 2014.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Andrea B Kelly, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182,
MSC 7770, Bethesda, MD 20892, (301) 455–
1761, kellya2@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group, Chemo/Dietary Prevention Study
Section.
Date: June 12, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Washington Marriott, 1221 22nd
Street NW., Washington, DC 20037.
Contact Person: Sally A Mulhern, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6198,
MSC 7804, Bethesda, MD 20892, (301) 408–
9724, mulherns@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group, Radiation Therapeutics and Biology
Study Section.
Date: June 16–17, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Bo Hong, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 6194, MSC 7804, Bethesda, MD
20892, 301–996–6208, hongb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Small
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
29199
Business: Cancer Drug Developments &
Therapeutics.
Date: June 17–18, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Lilia Topol, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6192,
MSC 7804, Bethesda, MD 20892, 301–451–
0131, ltopol@mail.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group, Cancer Biomarkers Study Section.
Date: June 18, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Lawrence Ka-Yun Ng,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6152,
MSC 7804, Bethesda, MD 20892, 301–357–
9318, ngkl@csr.nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group, Language and Communication Study
Section.
Date: June 19, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Washington DC,
Dupont Circle, 1143 New Hampshire Avenue
NW., Washington, DC 20037.
Contact Person: Biao Tian, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 3180, MSC 7848, Bethesda, MD
20892, 301–437–9858, tianbi@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Small
Business Grant Applications: Immunology.
Date: June 20, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The River Inn, 924 25th Street NW.,
Washington, DC 20037.
Contact Person: Stephen M. Nigida, Ph.D.,
Health Scientist Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4212,
MSC 7812, Bethesda, MD 20892, 301–435–
1222, nigidas@csr.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group,
Prokaryotic Cell and Molecular Biology
Study Section.
Date: June 20, 2014.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance M Street Hotel, 1143
New Hampshire Avenue NW., Washington,
DC 20037.
Contact Person: Dominique Lorang-Leins,
Ph.D., Scientific Review Officer, National
E:\FR\FM\21MYN1.SGM
21MYN1
29200
Federal Register / Vol. 79, No. 98 / Wednesday, May 21, 2014 / Notices
Institutes of Health, Center for Scientific
Review, 6701 Rockledge Drive, Room 5108,
MSC 7766, Bethesda, MD 20892,
301.326.9721, Lorangd@mail.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group, Genetic
Variation and Evolution Study Section.
Date: June 20, 2014.
Time: 8:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Guest Suites, 2515
Meridian Parkway, Research Triangle Park,
NC 27713.
Contact Person: Ronald Adkins, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2206,
MSC 7890, Bethesda, MD 20892, 301–435–
4511, ronald.adkins@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, RFA Panel:
Molecular Probes.
Date: June 20, 2014.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites DC Convention
Center, 900 10th NW., Washington, DC
20001.
Contact Person: Mary Custer, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4148,
MSC 7850, Bethesda, MD 20892, (301) 435–
1164, custerm@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS).
Dated: May 15, 2014.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–11649 Filed 5–20–14; 8:45 am]
BILLING CODE 4140–01–P
met in order to downlist this species to
threatened status or delist it under the
Endangered Species Act of 1973, as
amended (Act).
ADDRESSES: You may obtain a copy of
the recovery plan by contacting Dale
Suiter at the Raleigh Field Office, by
U.S. mail at U.S. Fish and Wildlife
Service, Raleigh Field Office, 551–F
Pylon Drive, Raleigh, North Carolina
27606; or by telephone at (919) 856–
4520, extension 18; or by visiting our
recovery plan Web site at https://
www.fws.gov/endangered/species/
recovery-plans.html.
FOR FURTHER INFORMATION CONTACT: Dale
Suiter, at the above address or by
telephone at (919) 856–4520, ext. 18.
SUPPLEMENTARY INFORMATION:
Introduction
We listed golden sedge as an
endangered species under the Act (16
U.S.C. 1531 et seq.), on January 23, 2002
(67 FR 3120), and designated critical
habitat for the species on March 1, 2011
(76 FR 11086). This species is a rare
perennial member of the sedge family
(Cyperaceae) endemic to the coastal
plain of North Carolina. It is currently
known from only 21 occurrences
(specific locations or sites) located
within a 16 by 5 mile area in Pender and
Onslow Counties. All eight populations
of this plant occur in the Northeast Cape
Fear River watershed in North Carolina.
Factors contributing to its endangered
status are an extremely limited range
and loss of habitat. The primary threat
is the loss or alteration of habitat, from
fire suppression; residential,
commercial, or industrial development;
mining; livestock grazing; and woody or
invasive species encroachment.
Background
DEPARTMENT OF THE INTERIOR
Fish and Wildlife Service
[FWS–R4–ES–2014–N05;
FXES111300400000C2–145–FF04E00000]
Endangered and Threatened Wildlife
and Plants; Notice of Availability of the
Final Recovery Plan for Golden Sedge
(Carex Lutea)
Fish and Wildlife Service,
Interior.
ACTION: Notice of availability.
mstockstill on DSK4VPTVN1PROD with NOTICES
AGENCY:
We, the Fish and Wildlife
Service, announce the availability of the
final recovery plan for golden sedge
(Carex lutea), a species endemic to the
coastal plain in North Carolina. The
final recovery plan includes specific
recovery objectives and criteria to be
SUMMARY:
VerDate Mar<15>2010
17:42 May 20, 2014
Jkt 232001
Restoring an endangered or
threatened animal or plant to the point
where it is again a secure, selfsustaining member of its ecosystem is a
primary goal of the endangered species
program. To help guide the recovery
effort, we are preparing recovery plans
for most listed species. Recovery plans
describe actions considered necessary
for conservation of the species, establish
criteria for downlisting or delisting, and
estimate time and cost for implementing
recovery measures.
The Act requires the development of
recovery plans for listed species, unless
such a plan would not promote the
conservation of a particular species.
Section 4(f) of the Act requires us to
provide a public notice and an
opportunity for public review and
comment during recovery plan
development.
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Recovery Plan Specifics
The objective of this plan is to
provide a framework for the recovery of
golden sedge so that protection under
the Act is no longer necessary. The draft
of this recovery plan was available for
public comment from June 18, 2013,
through August 19, 2013 (78 FR 36566).
We considered the information received
via public comments as well as from
peer reviewers in our preparation and
approval of this final recovery plan. We
also edited some sections of the draft
recovery plan to reflect these comments;
however, no substantial changes were
made to the draft recovery plan.
Criteria for Reclassification From
Endangered to Threatened
Golden sedge will be considered for
reclassification from endangered to
threatened status when all of the
following criteria are met:
1. There are 10 protected Carex lutea
sites in the wild that are distributed
across the range of the species. [Note:
Recovery sites will be considered
permanently protected when they are
placed under a conservation easement
or other binding land agreement and a
management agreement, and are ranked
as an A or B population by the North
Carolina Natural Heritage Program
(NCNHP).]
2. On each of the 10 Carex lutea sites,
for at least 5 years, any non-native plant
species that have the potential to
displace Carex lutea are maintained at
or below 10 percent of total number of
species and at or below 10 percent cover
(volume).
3. All 10 Carex lutea sites
demonstrate stable or increasing
population trends for 5 consecutive
years.
4. Habitat management plans are
actively being implemented for at least
seven of the protected sites.
5. A prescribed fire regime has been
developed and is being conducted at all
sites to mimic historical frequency and
timing (the frequency will be
determined through recovery actions in
this plan).
We define ‘‘protected’’ to mean the
site has been fee-simple acquired and
put into long-term conservation by a
local or State agency, or that a
conservation easement or other binding
land agreement has been placed on the
site by a landowner that shows a
commitment to its conservation in
perpetuity and Carex lutea from the site
is represented in a Center for Plant
Conservation (CPC)–approved seed
bank. In addition, each site should have
a management agreement/plan
developed. Prescribed fire should be
E:\FR\FM\21MYN1.SGM
21MYN1
]]>Agencies
[Federal Register Volume 79, Number 98 (Wednesday, May 21, 2014)]
[Notices]
[Pages 29199-29200]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-11649]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Bacterial Pathogenesis.
Date: June 9, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Richard G. Kostriken, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192, MSC 7808, Bethesda, MD
20892, 301-402-4454, kostrikr@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, RFA Panel: Animal Models and Human Investigation Cross-
Training.
Date: June 10, 2014.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Andrea B Kelly, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182, MSC 7770, Bethesda, MD
20892, (301) 455-1761, kellya2@csr.nih.gov.
Name of Committee: Oncology 2--Translational Clinical Integrated
Review Group, Chemo/Dietary Prevention Study Section.
Date: June 12, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Washington Marriott, 1221 22nd Street NW., Washington, DC
20037.
Contact Person: Sally A Mulhern, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6198, MSC 7804, Bethesda, MD
20892, (301) 408-9724, mulherns@csr.nih.gov.
Name of Committee: Oncology 2--Translational Clinical Integrated
Review Group, Radiation Therapeutics and Biology Study Section.
Date: June 16-17, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW., Washington, DC 20015.
Contact Person: Bo Hong, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6194, MSC 7804, Bethesda, MD 20892, 301-996-
6208, hongb@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Small Business: Cancer Drug Developments & Therapeutics.
Date: June 17-18, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Lilia Topol, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6192, MSC 7804, Bethesda, MD 20892, 301-451-
0131, ltopol@mail.nih.gov.
Name of Committee: Oncology 2--Translational Clinical Integrated
Review Group, Cancer Biomarkers Study Section.
Date: June 18, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW., Washington, DC 20015.
Contact Person: Lawrence Ka-Yun Ng, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6152, MSC 7804, Bethesda, MD
20892, 301-357-9318, ngkl@csr.nih.gov.
Name of Committee: Biobehavioral and Behavioral Processes
Integrated Review Group, Language and Communication Study Section.
Date: June 19, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Renaissance Washington DC, Dupont Circle, 1143 New
Hampshire Avenue NW., Washington, DC 20037.
Contact Person: Biao Tian, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3180, MSC 7848, Bethesda, MD 20892, 301-437-
9858, tianbi@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Small Business Grant Applications: Immunology.
Date: June 20, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The River Inn, 924 25th Street NW., Washington, DC 20037.
Contact Person: Stephen M. Nigida, Ph.D., Health Scientist
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4212, MSC 7812, Bethesda, MD
20892, 301-435-1222, nigidas@csr.nih.gov.
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group, Prokaryotic Cell and Molecular Biology Study Section.
Date: June 20, 2014.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Renaissance M Street Hotel, 1143 New Hampshire Avenue
NW., Washington, DC 20037.
Contact Person: Dominique Lorang-Leins, Ph.D., Scientific Review
Officer, National
[[Page 29200]]
Institutes of Health, Center for Scientific Review, 6701 Rockledge
Drive, Room 5108, MSC 7766, Bethesda, MD 20892, 301.326.9721,
Lorangd@mail.nih.gov.
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group, Genetic Variation and Evolution Study Section.
Date: June 20, 2014.
Time: 8:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Guest Suites, 2515 Meridian Parkway, Research
Triangle Park, NC 27713.
Contact Person: Ronald Adkins, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 2206, MSC 7890, Bethesda, MD 20892, 301-435-
4511, ronald.adkins@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, RFA Panel: Molecular Probes.
Date: June 20, 2014.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites DC Convention Center, 900 10th NW.,
Washington, DC 20001.
Contact Person: Mary Custer, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4148, MSC 7850, Bethesda, MD 20892, (301) 435-
1164, custerm@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS).
Dated: May 15, 2014.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-11649 Filed 5-20-14; 8:45 am]
BILLING CODE 4140-01-P
